HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Clinical trials for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer vaccine shield transplant patients from HPV?
⭐️ VACCINE ⭐️ OngoingThis study is testing how well the Gardasil 9 vaccine works to prevent HPV infection in cancer patients who have received a donor stem cell transplant. Researchers are giving the vaccine to 48 adult patients 6-12 months after their transplant to see if their immune systems can bu…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 19, 2026 14:55 UTC
-
New drug trial offers hope for stem cell transplant complications
Disease control OngoingThis study is testing whether the drug acalabrutinib can help control chronic graft-versus-host disease in adults who have had a stem cell transplant. The trial involves 51 participants whose condition worsened despite steroid treatment. Patients take the medication orally for up…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Targeted pill aims to block Cancer's growth signal in Tough-to-Treat tumors
Disease control OngoingThis study is testing an experimental pill called GSK2636771 for people with advanced cancers that have stopped responding to other treatments and have a specific genetic change called a PTEN mutation. The pill is designed to block a protein that these cancer cells may need to gr…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Targeted pill tested for Hard-to-Treat cancers with rare genetic flaws
Disease control OngoingThis study is testing a pill called trametinib for people with advanced cancers that have stopped responding to other treatments and have specific changes in a gene called BRAF. The pill aims to block proteins that these cancer cells need to grow. Researchers want to see if the t…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Can virtual coaching help cancer survivors live healthier lives?
Disease control OngoingThis study is testing different ways to help childhood and young adult cancer survivors become more physically active and improve their diets. Researchers are comparing several approaches including telehealth sessions with clinicians, personalized goal-setting with social media s…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Early trial for young cancer patients halted before starting
Disease control TerminatedThis early-phase study aimed to test the safety and effectiveness of a two-drug immunotherapy combination (nivolumab and ipilimumab) in children, teens, and young adults. It was specifically for patients whose cancers had returned or stopped responding to standard treatments and …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
Targeted drug tested for tough cancers with specific genetic flaw
Disease control OngoingThis study is testing a drug called trametinib for people with advanced cancers that have a specific genetic change called an NF1 mutation. The drug works by blocking proteins that these cancer cells may need to grow. Researchers want to see if trametinib can shrink these tumors …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test pill to supercharge radiation against brain cancer
Disease control OngoingThis early-stage study is testing a new oral drug called IPdR (ropidoxuridine) in combination with standard whole-brain radiation therapy. The goal is to see if the drug makes cancer cells in the brain more sensitive to radiation, potentially improving treatment for patients whos…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Targeted drug tested for Hard-to-Treat cancers with specific genetic flaw
Disease control OngoingThis study is testing if the drug trametinib can help control advanced cancers that have specific genetic changes called GNAQ or GNA11 mutations. It is for patients with various cancers, including solid tumors and lymphomas, that have not responded to other treatments. The goal i…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists test booster shot for Cancer-Killing cells
Disease control OngoingThis early-stage study is testing the safety of adding a drug called atezolizumab after a personalized immune cell therapy for patients with advanced blood or solid tumor cancers. The goal is to see if the drug helps the transferred immune cells survive longer and fight the cance…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New antibody drug enters human testing for Tough-to-Treat blood cancers
Disease control OngoingThis is a first-in-human study to find a safe dose of an experimental antibody drug called Hu8F4 for patients with advanced blood cancers like leukemia and myelodysplastic syndrome (MDS). The main goals are to check for side effects and see how the body processes the drug. The st…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Targeted drug tested against Hard-to-Treat cancers with genetic flaw
Disease control OngoingThis study is testing whether the drug palbociclib can shrink or stop the growth of advanced cancers that have specific genetic changes called CCND1, 2, or 3 amplification. The trial includes 40 patients with hard-to-treat solid tumors or lymphomas that have not responded to stan…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Fighting a stubborn virus: borrowed immune cells target CMV
Disease control OngoingThis study is testing a treatment for a viral infection called CMV that can be dangerous for people who have had a stem cell transplant. It uses special white blood cells from a donor who has fought off CMV before. The goal is to see if these 'borrowed' immune cells can help clea…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug tested to protect kidneys during cancer treatment
Disease control OngoingThis study is testing if a drug called pegloticase can quickly lower dangerously high uric acid levels in cancer patients. High uric acid is a side effect of some cancer treatments and can damage the kidneys. The goal is to see if one or two doses of pegloticase can protect kidne…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Targeted drug trial offers new hope for Tough-to-Treat cancers
Disease control OngoingThis study is testing whether a drug called afatinib can help people with advanced cancers that have a specific genetic change called a HER2 mutation. The drug works by blocking a protein that helps cancer cells grow. Researchers are enrolling about 40 patients whose cancers have…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
New transplant strategy aims to tame blood cancers and reduce rejection
Disease control OngoingThis study is testing a modified stem cell transplant procedure for patients with high-risk blood cancers. The goal is to see if using specific chemotherapy drugs in a timed sequence before and after the transplant can better control the cancer while reducing harmful immune react…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Drug duo aims to block Cancer's growth signal in Hard-to-Treat tumors
Disease control OngoingThis study is testing whether two drugs, dabrafenib and trametinib, can shrink or stop the growth of advanced cancers that have a specific genetic change called a BRAF V600 mutation. It is for patients with solid tumors, lymphoma, or multiple myeloma that have not responded to ot…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Targeted drug trial aims to block growth signal in tough cancers
Disease control OngoingThis study is testing a drug called defactinib in people with advanced cancers that have stopped responding to other treatments and have a specific genetic change called an NF2 mutation. The drug aims to block a protein that these cancer cells may need to grow. Researchers want t…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Can a home workout and a pill fight diabetes risk in cancer survivors?
Disease control OngoingThis small pilot study is testing whether a simple home exercise program, with or without a vitamin B3-like supplement, is a practical way to help adult survivors of childhood cancer who have prediabetes. The goal is to see if this approach can improve muscle health and how the b…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Cancer trial matches drugs to your Tumor's DNA
Disease control OngoingThis large national trial is testing whether choosing cancer drugs based on the specific genetic changes found in a patient's tumor is more effective than standard approaches. It is for adults with advanced solid tumors, lymphoma, or multiple myeloma that have progressed after at…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Targeted drug trial aims to slow advanced cancers by blocking key mutation
Disease control OngoingThis trial is testing whether the drug osimertinib can help control advanced cancers that have specific changes (mutations) in a gene called EGFR. The drug works by blocking the faulty protein these mutations create, which may slow or stop cancer growth. The study is for adults w…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New drug targets Cancer's genetic weakness
Disease control OngoingThis study is testing an experimental drug called taselisib for people with advanced cancers that have a specific genetic change called a PIK3CA mutation. The drug aims to block a protein that helps cancer cells grow, with the goal of shrinking tumors or stopping their growth. It…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
New Team-Based care aims to help seniors bounce back after cancer transplant
Disease control OngoingThis study is testing whether a team of different healthcare specialists can help older adults with blood cancer prepare for and recover from a stem cell transplant. The team includes doctors, therapists, a dietitian, and a social worker who work with patients for three months be…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Targeted drug trial aims to block Cancer's growth signal
Disease control OngoingThis study is testing if the drug crizotinib can shrink or stop the growth of advanced cancers that have a specific genetic change called an ALK rearrangement. It is for people with various solid tumors or blood cancers (excluding certain lung cancers and lymphomas) that have not…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Targeted drug trial aims to block Cancer's growth signal
Disease control OngoingThis study is testing whether the drug crizotinib can shrink or stop the growth of advanced cancers that have a specific genetic change called a ROS1 translocation. The trial is for patients with various hard-to-treat cancers (like certain solid tumors, lymphomas, or myeloma) tha…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Smart bomb drug trial targets tough cancers with genetic flaw
Disease control OngoingThis trial is testing a targeted drug called ado-trastuzumab emtansine for patients with advanced cancers that have a specific genetic change called HER2 amplification. The drug is designed to find cancer cells with the HER2 marker and deliver chemotherapy directly to them. The s…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC
-
New method aims to protect babies from harsh chemo side effects
Disease control OngoingThis study is testing a new way to calculate the dose of the cancer drug vincristine for infants and very young children. The goal is to give them drug levels in their blood that are similar to older children, who use a standard dosing method, while trying to reduce severe side e…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
New drug targets a key Cancer-Causing mutation
Disease control OngoingThis study is testing a drug called binimetinib in patients with advanced cancers that have a specific genetic change called an NRAS mutation. The drug works by blocking proteins that cancer cells with this mutation need to grow. Researchers want to see if the drug can shrink the…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
New targeted therapy trial offers hope for hard-to-treat cancers with specific genetic flaw
Disease control OngoingThis study is testing whether the drug AZD5363 can help control advanced cancers that have a specific genetic change called an AKT mutation. The trial includes 35 patients with various cancers (solid tumors, lymphoma, or myeloma) that have stopped responding to standard treatment…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
New drug targets weakness in BRCA cancer cells
Disease control OngoingThis study is testing whether the drug AZD1775 can shrink or stop the growth of advanced cancers that have specific genetic changes called BRCA1 or BRCA2 mutations. The drug works by blocking a protein called WEE1 that these cancer cells may need to survive. The trial will involv…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
Targeted pill tested to control tough cancers with missing protein
Disease control OngoingThis study is testing an experimental pill called GSK2636771 for people with advanced cancers that have stopped responding to other treatments. The drug is specifically for cancers that have completely lost a protein called PTEN. Researchers want to see if the pill can shrink the…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC
-
Home heart monitors could catch problems earlier for cancer survivors
Diagnosis OngoingThis study is testing whether portable heart monitoring devices used at home can detect early heart problems in childhood cancer survivors as accurately as standard clinic tests. Researchers are comparing two portable systems against echocardiograms and MRI scans to see if home m…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Apr 01, 2026 18:25 UTC
-
Vaccinating donors to arm transplant patients against dangerous virus
Prevention OngoingThis study is testing a new approach to prevent a common and dangerous viral infection called CMV in people receiving a stem cell transplant for blood cancer. Researchers are giving a vaccine to the healthy stem cell donors before the transplant. The goal is to see if the donor's…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Mar 25, 2026 14:08 UTC
-
New vaccine aims to shield vulnerable cancer patients from dangerous virus
Prevention OngoingThis study is testing a vaccine designed to prevent cytomegalovirus (CMV) infection in adults with blood cancers who are receiving a half-matched stem cell transplant. CMV is a common virus that can become life-threatening when the immune system is weakened after transplant. The …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Mar 16, 2026 15:25 UTC
-
Cancer's hidden cost: new program aims to ease financial pain for patients
Symptom relief OngoingThis study tests whether a financial counseling program can reduce money problems and stress for people with cancer and their partners. It compares two groups: one gets basic financial education, and the other gets that plus monthly meetings with a financial counselor. The goal i…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: SWOG Cancer Research Network • Aim: Symptom relief
Last updated Apr 01, 2026 18:26 UTC
-
New combo therapy aims to ease sleepless nights for cancer patients
Symptom relief OngoingThis study is testing a combination of treatments to help cancer patients who are having trouble sleeping. It combines counseling sessions with possible use of a stimulant, melatonin, and light therapy. The goal is to see if this package improves sleep quality, reduces fatigue, a…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Can a natural supplement soothe Chemo's painful side effects?
Symptom relief OngoingThis study is testing if a dietary supplement called PEA can relieve nerve pain, numbness, and tingling caused by chemotherapy in cancer survivors. About 88 participants who have had these symptoms for at least 3 months will take either PEA or a placebo pill for 8 weeks. Research…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
App aims to lift spirits for cancer patients battling depression
Symptom relief OngoingThis study is testing whether adding a special digital app and web platform can improve depression care for people undergoing cancer treatment. It compares this tech-enhanced approach to the usual collaborative care methods. The goal is to see if the technology helps patients and…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
Doctors test if slower pain shots reduce addiction risk in cancer patients
Symptom relief OngoingThis study aims to find the best way to give intravenous pain medicine to hospitalized cancer patients. Researchers are comparing whether giving the drug hydromorphone quickly over 2 minutes or slowly over 15 minutes provides better pain relief while lowering the risk of patients…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:29 UTC
-
Can a fitbit and social media help young cancer survivors get healthier?
Symptom relief OngoingThis study is testing a mobile health program designed to help young people who have survived childhood cancer become more physically active. It compares a full program—which includes a Fitbit, personalized goal setting, and a social media support group—against just wearing a Fit…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC
-
Phone app aims to guide cancer patients through radiation treatment
Symptom relief OngoingThis study is testing a new mobile phone app designed to help cancer patients during radiation therapy. The app provides education and guidance on managing treatment side effects and logistics. Researchers want to see if patients find the app easy to use and helpful. The study in…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:17 UTC
-
Can walking and light weights beat drugs for chemo pain?
Symptom relief OngoingThis study is testing if a simple, home-based exercise program can better relieve the nerve pain, numbness, and tingling that often follows chemotherapy. About 133 cancer patients who have this side effect are being assigned to either follow a 6-week walking and resistance progra…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: University of Rochester NCORP Research Base • Aim: Symptom relief
Last updated Mar 18, 2026 14:42 UTC
-
Cancer breathlessness breakthrough? opioid study aims to ease suffering
Symptom relief OngoingThis study is testing if fast-acting opioid medications, normally used for pain, can help control the distressing shortness of breath cancer patients feel during physical activity. It will compare two opioids (fentanyl and morphine) against a placebo in 150 patients. The main goa…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 10, 2026 12:53 UTC
-
Major study investigates why cancer treatments work differently across racial groups
Knowledge-focused OngoingThis study aims to understand if Black and White cancer patients experience different side effects and treatment results when receiving immunotherapy drugs. Researchers will follow 2,100 patients already scheduled to receive these treatments in community cancer clinics. By collec…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: University of Rochester NCORP Research Base • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Researchers ask teens: how do we measure your cancer pain?
Knowledge-focused OngoingThis study is testing a symptom questionnaire designed specifically for teenagers with cancer. Researchers are interviewing 13-17 year old cancer patients to see if the questionnaire accurately captures their experiences with pain, fatigue, and other symptoms. The goal is to crea…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Parents' fear of opioids for kids in pain: cancer center investigates
Knowledge-focused OngoingThis study aims to understand the worries parents have about giving opioid pain medication to their children with cancer. Researchers are surveying 110 parents to learn why some might hesitate to use these strong pain relievers, even when their child is hurting. The information w…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Can they hear us? brain wave study seeks answers for families of dying patients
Knowledge-focused TerminatedThis study uses brain wave monitoring to understand if cancer patients who appear completely unresponsive near the end of life can still hear or understand words. Researchers will measure brain activity in response to speech and other stimuli in 30 patients. The goal is to provid…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Scientists probe hidden heart risks in cancer survivors
Knowledge-focused OngoingThis study aims to understand why people who survive a blood cancer transplant have a higher risk of heart disease. Researchers will closely monitor 350 adult patients' heart, lung, and muscle function before their transplant and for two years after. The goal is to learn how thes…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Scientists test new 'Tumor Glow' scan for Hard-to-Spot cancers
Knowledge-focused OngoingThis early-stage study is testing a new imaging agent called 68Ga-FAPI-46 to see where it goes in the body of patients with many different types of cancer. The goal is to understand if this tracer can help doctors better see and understand tumors by highlighting specific cells ar…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Cancer's hidden cost: study probes financial stress on patients
Knowledge-focused OngoingThis study aims to understand the financial stress cancer patients experience and what personal and social factors help them cope. Researchers are surveying 625 recently diagnosed patients to learn how their confidence, support networks, and financial knowledge relate to this str…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Massive study asks: how did COVID-19 impact cancer Patients' lives?
Knowledge-focused OngoingThis study aims to understand how the COVID-19 pandemic affected the well-being and quality of life of cancer patients and survivors. Researchers are surveying over 13,000 patients about their pandemic experiences, including health impacts, financial stress, and emotional challen…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Cancer patients weigh in: does adding marijuana to pain meds help?
Knowledge-focused OngoingThis study aims to understand cancer patients' preferences and experiences when using marijuana products (THC or CBD) alongside prescription opioids for pain. Researchers are surveying 200 patients with cancer-related pain in Texas and Arizona to learn which combination they find…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Does a mask hide a Doctor's care? study tests patient feelings on video vs. In-Person visits
Knowledge-focused OngoingThis study aims to understand how patients with cancer or COVID-19 perceive their doctor's empathy. Researchers are comparing two visit types: in-person where the doctor wears full protective equipment (PPE) versus a video call where the doctor does not. The goal is to learn whic…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Researchers ask: did pandemic worsen pain for cancer survivors?
Knowledge-focused OngoingThis study aims to learn how the COVID-19 pandemic affected the quality of life of cancer patients who also have nerve pain (neuropathy). Researchers are surveying 274 patients who were in previous studies to see if their pain, anxiety, and daily life were impacted. They also wan…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Mayo clinic aims to break down barriers for minority patients in cancer trials
Knowledge-focused OngoingThis study aims to understand why minority and underserved cancer patients often do not join clinical trials. Researchers are surveying patients about their knowledge and attitudes, then testing a personalized educational platform designed to provide clear information and support…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC
-
Could low testosterone be a hidden cause of dementia?
Knowledge-focused OngoingThis study aims to understand if low testosterone levels might increase a person's risk of developing dementia, depression, or anxiety. Researchers will analyze existing genetic and health data from large public biobanks, not recruit new participants. The goal is to gather knowle…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC
-
Cancer patients and doctors weigh in: is telemedicine here to stay?
Knowledge-focused OngoingThis study aims to understand what cancer patients and their radiation doctors think about using video calls for appointments. Researchers are surveying 200 people who have already had a telemedicine visit for cancer care. The goal is to learn about satisfaction, identify challen…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC
-
Could cancer patients skip the hospital? study probes home care safety
Knowledge-focused TerminatedThis study aimed to gather information to help design future 'hospital at home' programs for cancer patients with fever and low white blood cell counts. Researchers planned to review medical records to see how often these patients had serious complications and what treatments the…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:52 UTC
-
Can a simple 15-Minute check predict survival for older cancer patients?
Knowledge-focused OngoingThis study aims to find the best way to spot malnutrition in older adults with cancer. Researchers will test four different screening methods to see which one best predicts a patient's risk of dying or needing unplanned hospital care over the next year. The goal is to improve how…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:52 UTC
-
Can video chats cure doctor burnout? cancer center tests new model
Knowledge-focused OngoingThis study is testing whether regular virtual team meetings can help cancer imaging specialists feel less burned out and more connected to their colleagues. Researchers want to see if this telementoring program is practical and if it improves doctors' well-being and job satisfact…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:25 UTC